Eli Lilly's bid for Orna Therapeutics cleared by Australian watchdog
MLex Summary: Eli Lilly's proposal to acquire 100 percent of the issued shares in Orna Therapeutics has been cleared by Australia's competition watchdog. In a Monday statement, the Australian Competition and Consumer...To view the full article, register now.
Already a subscriber? Click here to view full article